BONYF NV Announces 2024 Annual Results
On June 30, 2025, BONYF NV, a leader in dental care innovation, released its financial statements for the year 2024. The company, listed on the Euronext Paris, specializes in the development, production, and marketing of oral, denture, orthodontic, and wound care products. The financial statements, approved by the Board of Directors and audited by statutory auditors, were presented in Knokke-Heist, Belgium.
Key Highlights from the Annual Results
- Patented Formulations: BONYF NV continues to leverage its portfolio of products with patented formulations, ensuring a competitive edge in the market.
- Quality Production: The company maintains its production standards in Switzerland, adhering to stringent international quality regulations.
- Clinical Efficacy: BONYF NV’s products have proven clinical efficacy, reinforcing their reputation in the oral and dental care industry.
- Global Presence: With a commercial presence in 37 countries, BONYF NV is well-positioned to capitalize on the fast-growing oral and dental care market.
- Growth Prospects: The company anticipates solid growth and rapid profitability, driven by its innovative product offerings and expanding market reach.
About BONYF NV
Founded in 1979, BONYF NV has been at the forefront of oral and dental care innovation. The company is committed to revolutionizing oral care through continuous innovation and research. With a focus on quality and efficacy, BONYF NV develops cutting-edge products designed to enhance the well-being of individuals worldwide.
For more detailed information, stakeholders are encouraged to visit bonyf.com or contact investor@bonyf.com .
Financial Overview
- Close Price (June 26, 2025): €13.9
- 52 Weeks High (February 24, 2025): €19.5
- 52 Weeks Low (June 26, 2025): €13.9
BONYF NV’s strategic focus on innovation and quality positions it well for continued success in the dynamic oral and dental care market.